Sales climbed by 8.2 % from KEUR 64,446 (6M-2018) to KEUR 69,708 in the first half of 2019. Consolidated EBIT improved by 13.4 % to KEUR 7,488 (6M-2018: KEUR 6,605). EBITA climbed by 12.9 % from KEUR 8,194 (6M-2018) to KEUR 9,247. EBITDA rose by 25.6 % (adjusted for IFRS 16
effect: 8.7 %) to KEUR 15,417 (adjusted for IFRS 16 effect: KEUR 13,340) (6M-2018: KEUR 12,276). Consolidated net income is up by 2.6 % at KEUR 5,346 in the first half of 2019 after KEUR 5,212.
Operating cash amounted to KEUR 28,871 after the strong prior-year figure (6M-2018: KEUR 18,268). NEXUS AG had cash funds including current financial assets of KEUR 36,432 as of 30 June 2019 (30 June 2018: KEUR 25,129). A dividend of KEUR 2,676 (2018: KEUR 2,519) was paid to our stockholders in 2019. Earnings per share amounted to EUR 0.27 in the first half of the year (previous year: EUR 0.32).
NEXUS AG had equity of KEUR 109,081 as of 30 June 2019 (31 December 2018: KEUR 108,325). NEXUS AG therefore has a consistently healthy statement of financial position and sufficient capital to continue financing its European growth strategy.
The detailed Half-Year Report can be found on our homepage at:
https://en-en.nexus-ag.de/company/news/half-year-report-2019
NEXUS AG is one of the leading healthcare software companies in Europe. With more than 1,200 employees we supply hospitals, rehabilitation institutions and senior citizen homes all over the world with IT applications.
NEXUS AG
Irmastraße 1
78166 Donaueschingen
Telefon: +49 (771) 22960-0
Telefax: +49 (771) 22960-999
https://www.nexus-ag.de
Investor Relations
Telefon: +49 (771) 22960-260
Fax: +49 (771) 22960-266
E-Mail: melanie.ilic@nexus-ag.de
